Gene Expression Profiling Confirms the Dosage-Dependent Additive Neuroprotective Effects of Jasminoidin in a Mouse Model of Ischemia-Reperfusion Injury

Figure 5

Signal transduction-neuropeptides signaling pathways. They contain 28 target genes, with 23 and 17 in JA and 2·JA, respectively. Among them, 12 target molecules were activated by both dosages (in black); 2 were only activated in the JA (in blue) group, while 5 were specific to 2·JA (in red) treatment.